< Back to previous page
Researcher
Rob Lavigne
- Disciplines:Animal biology, Biological system engineering, Signal processing, Agricultural animal production
Affiliations
- Animal and Human Health Engineering (A2H) (Division)
Responsible
From1 Aug 2023 → Today - Animal and Human Health Engineering (A2H) (Division)
Member
From1 Aug 2020 → Today - Division Animal and Human Health Engineering (Division)
Member
From1 Aug 2015 → 31 Jul 2020 - Department of Biosystems (BIOSYST) (Department)
Member
From1 Aug 2006 → 30 Sep 2006
Projects
41 - 50 of 80
- BurnzymesFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- PhageBioticsFrom1 Jan 2019 → 31 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Cell-PHactory: Exploiting phage as a source of novel synthetic biology tools to improve industrial fermentations.From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Engineering Pseudomonas aeruginosa towards the development of minimal phage genomesFrom2 Oct 2018 → 2 Oct 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Novel potent miniDNases in biotechnogical, industrial and medical applicationsFrom1 Sep 2018 → 30 Sep 2020Funding: IOF - Industrial Research Fund
- VIROME NGS ANALYSIS OF PESTS AND PATHOGENS FOR PLANT PROTECTION.From1 May 2018 → 31 Oct 2021Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Exploiting an unusual polyketide chain release mechanism for the production of novel antibiotic analoguesFrom1 Oct 2017 → 15 Sep 2022Funding: FWO fellowships
- The application of the unique phage-derived miniDNase in a medical and industrial contextFrom1 Oct 2017 → 31 Dec 2021Funding: FWO Strategic Basic Research Grant
- Optimization of phage therapy against bacterial pathogens in cabbage and leekFrom1 Oct 2016 → 30 Sep 2020Funding: IWT / VLAIO - Agricultural research
- Comparative genomics of pathogenic bacteriaFrom29 Sep 2016 → 31 Dec 2021Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 346
- Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis.(2024)
Authors: Rob Lavigne
Pages: 118 - Complete genome sequences of two Leuconostoc carnosum strains: 4010 and AMS1(2024)
Authors: Cédric Lood, Rob Lavigne
- Phage proteins target and co-opt host ribosomes immediately upon infection.(2024)
Authors: Laura Wicke, Rob Lavigne
Pages: 787 - 800 - Meeting Report of the Second Symposium of the Belgian Society for Viruses of Microbes and Launch of the Phage Valley(2024)
Authors: Rob Lavigne, Jelle Matthijnssens, Jeroen Wagemans
- Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections(2024)
Authors: Jeroen Wagemans, Rob Lavigne, Annabel Braem
- Tail-tape-fused virion and non-virion RNA polymerases of a thermophilic virus with an extremely long tail(2024)
Authors: Maarten Boon, Rob Lavigne
- FLAMS: Find Lysine Acylations and other Modification Sites(2024)
Authors: Hannelore Longin, Nand Broeckaert, Maarten Langen, Hanne Hendrix, Rob Lavigne, Vera van Noort
- Refining the transcriptional landscapes for distinct clades of virulent phages infecting Pseudomonas aeruginosa.(2024)
Authors: Maarten Boon, Vera van Noort, Rob Lavigne
Pages: uqae002 - Impact of phage predation on P. aeruginosa adhered to human airway epithelium: major transcriptomic changes in metabolism and virulence-associated genes(2023)
Authors: Leena Putzeys, Jan Paeshuyse, Rob Lavigne
Pages: 235 - 247 - The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa(2023)
Authors: Kaat Schroven, Leena Putzeys, Jan Paeshuyse, Rob Lavigne
Patents
1 - 10 of 10
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- Novel dnase (Inventor)
- New endolysin obpgplys (Inventor)
- Polynucleotide shuffling method (Inventor)
- Novel dnase (Inventor)
- Antimicrobial agents (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)